
VolitionRx Limited VNRX
$ 0.21
12.86%
Quarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited EV/EBITDA Ratio 2011-2026 | VNRX
Annual EV/EBITDA Ratio VolitionRx Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.45 | - | -11.2 | -4.04 | -6.02 | -7.16 | -6.29 | -11.3 | -6.37 | 339 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 339 | -11.3 | 31.4 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
Illumina
ILMN
|
70.5 | $ 123.79 | -0.43 % | $ 19.7 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.13 | -2.74 % | $ 4.89 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 25.75 | 3.0 % | $ 715 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.1 | 1.76 % | $ 1.04 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 104.91 | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
21 | $ 17.51 | 1.1 % | $ 392 M | ||
|
Natera
NTRA
|
-19.5 | $ 200.09 | 2.46 % | $ 19.7 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
OPKO Health
OPK
|
25.9 | $ 1.15 | 2.68 % | $ 798 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
-7.07 | $ 7.61 | 4.82 % | $ 451 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 158.0 | 2.86 % | $ 7.83 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 166.96 | 0.54 % | $ 28.7 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 75.73 | -0.92 % | $ 5.11 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 578.51 | 0.22 % | $ 46.5 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.46 | 26.96 % | $ 1.86 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 456.93 | 0.98 % | $ 13.2 B | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.62 | 2.16 % | $ 276 M | ||
|
Sotera Health Company
SHC
|
24.8 | $ 13.88 | 2.81 % | $ 3.94 B | ||
|
Agilent Technologies
A
|
27.4 | $ 112.02 | 0.65 % | $ 34.1 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 100.35 | 0.65 % | $ 8.28 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 31.72 | -4.52 % | $ 1.61 B | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 7.5 | -6.13 % | $ 29.9 M | ||
|
Guardant Health
GH
|
-28.8 | $ 84.9 | -0.33 % | $ 10.6 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.66 | 1.75 % | $ 432 M | ||
|
Psychemedics Corporation
PMD
|
15.9 | - | -1.84 % | $ 15.3 M | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.6 | 10.34 % | $ 106 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 239.07 | 2.87 % | $ 25.5 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.56 | 2.39 % | $ 936 M | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.48 | 0.87 % | $ 1.87 M | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 478.12 | 0.79 % | $ 180 B | ||
|
Celcuity
CELC
|
-2.38 | $ 106.75 | 0.67 % | $ 4.21 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 264.42 | 0.54 % | $ 22 B |